comparemela.com

Latest Breaking News On - Virtuos lyograft - Page 1 : comparemela.com

Orthofix beats The Street in Q3 results, raises full-year guidance

Orthofix (Nasdaq:OFIX) this week posted third-quarter results that beat the overall consensus on Wall Street.

United statesJon serbousekVirtuos lyograftMassdevice medtechBone growth therapiesAccelstim bone healing therapy

First patients implanted with Orthofix Legacy demineralized bone matrix

Orthofix (Nasdaq:OFIX) announced today that it completed the full market release and first implants of its Legacy demineralized bone matrix.

Rhode islandUnited statesCalan danielsVirtuos lyograftKevin kennyUniversity orthopedics in providenceTexas based orthofixUniversity orthopedicsTrinity elite fiberfuseFiberfuse strip

Orthofix Medical Inc s (OFIX) CEO Jon Serbousek on Q2 2022 Results - Earnings Call Transcript

Orthofix Medical Inc. (NASDAQ:NASDAQ:OFIX) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Alexa Huerta – Senior Director-Investor Relations Jon Serbousek –.

United statesMathew blackmanJon serbousekJeffrey cohenVirtuos lyograftJim sidotiAlexa huertaCompany participantsOrthofix medical incFrench ministry of healthOrthofix medicalConference call augustSenior director investorChief executiveChief financialSenior director

Orthofix lowers full-year revenue guidance on missed Q2 results

Orthofix (Nasdaq:OFIX) this week reported second-quarter results that missed the overall consensus on Wall Street.

United statesJon serbousekVirtuos lyograft

Orthofix announces first clinical use of its autograft substitute

Orthofix Medical today announced the limited market release and first implant of its Virtuos Lyograft autograft substitute.

United statesTomas ellisBaylor scottVirtuos lyograftKevin kennyOrthofix medicalTexas based orthofixWhite surgical hospitalFort worthTrinity eliteTrinity evolutionFiberfuse advancedFiberfuse stripOrthofix presidentGlobal spine kevin

vimarsana © 2020. All Rights Reserved.